ZIKARON Trademark

Trademark Overview

On Thursday, July 1, 2004, a trademark application was filed for ZIKARON with the United States Patent and Trademark Office. The USPTO has given the ZIKARON trademark a serial number of 78444419. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 20, 2009. This trademark is owned by Teva Pharmaceutical Industries Ltd.. The ZIKARON trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of central nervous system disorders, including Parkinson's disease, Alzheimer's disease, ALS, stroke, brain injury, immune system disorders and autoimmune diseases
zikaron

General Information

Serial Number78444419
Word MarkZIKARON
Filing DateThursday, July 1, 2004
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 20, 2009
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 27, 2005

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of central nervous system disorders, including Parkinson's disease, Alzheimer's disease, ALS, stroke, brain injury, immune system disorders and autoimmune diseases
Translation of Words in MarkThe foreign wording in the mark translates into English as recollection.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, July 8, 2004
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTeva Pharmaceutical Industries Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressJerusalem 91010
IL
Party NameTeva Pharmaceutical Industries Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressJerusalem 91010
IL

Trademark Events

Event DateEvent Description
Monday, April 20, 2009ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, April 20, 2009ABANDONMENT - NO USE STATEMENT FILED
Friday, August 15, 2008EXTENSION 5 GRANTED
Friday, August 15, 2008EXTENSION 5 FILED
Friday, August 15, 2008TEAS EXTENSION RECEIVED
Friday, January 25, 2008EXTENSION 4 GRANTED
Friday, January 25, 2008EXTENSION 4 FILED
Friday, January 25, 2008TEAS EXTENSION RECEIVED
Wednesday, July 25, 2007EXTENSION 3 GRANTED
Wednesday, July 25, 2007EXTENSION 3 FILED
Wednesday, July 25, 2007TEAS EXTENSION RECEIVED
Friday, February 23, 2007EXTENSION 2 GRANTED
Friday, February 23, 2007EXTENSION 2 FILED
Friday, February 23, 2007TEAS EXTENSION RECEIVED
Monday, June 26, 2006EXTENSION 1 GRANTED
Monday, June 26, 2006EXTENSION 1 FILED
Monday, June 26, 2006TEAS EXTENSION RECEIVED
Tuesday, March 21, 2006NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 27, 2005PUBLISHED FOR OPPOSITION
Wednesday, December 7, 2005NOTICE OF PUBLICATION
Wednesday, November 2, 2005LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, October 28, 2005ASSIGNED TO LIE
Sunday, October 23, 2005APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, September 2, 2005TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, August 26, 2005CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, August 26, 2005TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, August 17, 2005AMENDMENT FROM APPLICANT ENTERED
Tuesday, August 9, 2005CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 9, 2005PAPER RECEIVED
Monday, February 7, 2005NON-FINAL ACTION MAILED
Sunday, February 6, 2005NON-FINAL ACTION WRITTEN
Sunday, February 6, 2005ASSIGNED TO EXAMINER
Thursday, July 8, 2004NEW APPLICATION ENTERED IN TRAM

Related Keywords

zikaron system disease disorders stroke brain injury diseases autoimmune immune alzheimer